ReviewThe American journal of case reports2026
Fatal Status Epilepticus After Elective Revision Cranioplasty: Case Report and Literature Review.
Review in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Cranioplasty is a common neurosurgical procedure performed to correct skull defects after prior surgical intervention or cranial injury. Although frequently performed, the rate of adverse events remains relatively high, and seizures are a commonly reported complication. Despite these complication rates, surgical mortality is not typically associated with cranioplasty, and status epilepticus (SE) is a relatively rare occurrence. We report a case of refractory SE after elective revision cranioplasty that ultimately resulted in death. CASE REPORT A 76-year-old man underwent revision titanium cranioplasty due to symptomatic subsidence of a previously implanted acrylic plate. Immediately following an uncomplicated procedure, the patient developed refractory generalized seizures that progressed to nonconvulsive SE. The seizures were unresponsive to maximal medical therapy, and the patient died 4 weeks after the procedure. CONCLUSIONS The causes of refractory SE after cranioplasty are not fully understood and have been proposed to include focal brain injury, alterations in transmantle pressure, and the use of negative-pressure drains. Prophylactic perioperative administration of antiepileptic drugs may reduce the incidence of seizures and SE after revision cranioplasty. Once SE has developed, established treatment modalities include antiepileptic drugs and sedation; consideration may also be given to infusion of dexmedetomidine, removal of the cranioplasty, and insertion of a vagal nerve stimulator.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.